The metabolic syndrome and inflammation: association or causation?

被引:181
作者
Esposito, K [1 ]
Giugliano, D [1 ]
机构
[1] Univ Naples 2, Dept Geriatr & Metab Dis, Ctr Eccellenza Cardiovascolare, Naples, Italy
关键词
metabolic syndrome; low-grade inflammation; insulin resistance; adipokines; C-reactive protein; cardiovascular risk;
D O I
10.1016/S0939-4753(04)80048-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this editorial was to discuss evidence indicating a role for low-grade inflammation as a pathogenetic event Of the metabolic syndrome. The metabolic syndrome has emerged as an important cluster of risk factors for atherosclerotic disease. Common features are central (abdominal) obesity, insulin resistance, hypertension, and dyslipidemia, namely high triglycerides and low high-density lipoprotein cholesterol. According to the clinical criteria developed by ATP III, it has been estimated that 1 out of 4 adults living in the United States merits the diagnosis. The presence of the metabolic syndrome is highly prognostic of future cardiovascular events. Chronic inflammation may represent a triggering factor in the origin of the metabolic syndrome: stimuli such as overnutrition, physical inactivity, and ageing would result in cytokine hypersecretion and eventually lead to insulin resistance and diabetes in genetically or metabolically predisposed individuals. Alternatively, resistance to the anti-inflammatory actions of insulin would result in enhanced circulating levels of proinflammatory cytokines resulting in persistent low-grade inflammation. A generally enhanced adipose tissue derived cytokine expression may be another plausible mechanism for the inflammation/metabolic syndrome relationship. The role of adipose tissue as an endocrine organ capable of secreting a number of adipose tissue-specific or enriched hormones, known as adipokines, is gaining appreciation. Although the precise role of adipokines in the metabolic syndrome is still debated, an imbalance between increased inflammatory stimuli and decreased anti-inflammatory mechanisms may be an intriguing working hypothesis. The proinflammatory state that accompanies the metabolic syndrome associates with both insulin resistance and endothelial dysfunction, providing a connection between inflammation and metabolic processes which is highly deleterious for vascular functions. (C) 2004, Medikal Press.
引用
收藏
页码:228 / 232
页数:5
相关论文
共 37 条
  • [1] Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
    Bastard, JP
    Jardel, C
    Bruckert, E
    Blondy, P
    Capeau, J
    Laville, M
    Vidal, H
    Hainque, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) : 3338 - 3342
  • [2] Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo
    Bhagat, K
    Vallance, P
    [J]. CIRCULATION, 1997, 96 (09) : 3042 - 3047
  • [3] Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction
    Boden, G
    Shulman, GI
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 : 14 - 23
  • [4] Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome - Nested case-control study
    Brunner, EJ
    Hemingway, H
    Walker, BR
    Page, M
    Clarke, P
    Juneja, M
    Shipley, MJ
    Kumari, M
    Andrew, R
    Seckl, JR
    Papadopoulos, A
    Checkley, S
    Rumley, A
    Lowe, GDO
    Stansfeld, SA
    Marmot, MG
    [J]. CIRCULATION, 2002, 106 (21) : 2659 - 2665
  • [5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [6] The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm
    Dandona, P
    Aljada, A
    Mohanty, P
    [J]. DIABETOLOGIA, 2002, 45 (06) : 924 - 930
  • [7] PHYSIOLOGICAL INCREMENTS IN PLASMA-INSULIN CONCENTRATIONS HAVE SELECTIVE AND DIFFERENT EFFECTS ON SYNTHESIS OF HEPATIC PROTEINS IN NORMAL HUMANS
    DEFEO, P
    VOLPI, E
    LUCIDI, P
    CRUCIANI, G
    REBOLDI, G
    SIEPI, D
    MANNARINO, E
    SANTEUSANIO, F
    BRUNETTI, P
    BOLLI, GB
    [J]. DIABETES, 1993, 42 (07) : 995 - 1002
  • [8] Association of low interleukin-10 levels with the metabolic syndrome in obese women
    Esposito, K
    Pontillo, A
    Giugliano, F
    Giugliano, G
    Marfella, R
    Nicoletti, G
    Giugliano, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) : 1055 - 1058
  • [9] Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women
    Fernandez-Real, JM
    Vayreda, M
    Richart, C
    Gutierrez, C
    Broch, M
    Vendrell, J
    Ricart, W
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) : 1154 - 1159
  • [10] Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS)
    Festa, A
    D'Agostino, R
    Howard, G
    Mykkänen, L
    Tracy, RP
    Haffner, SM
    [J]. CIRCULATION, 2000, 102 (01) : 42 - 47